These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 2213164)

  • 21. Immunocytochemical study of progesterone receptor in human meningioma.
    Perrot-Applanat M; Groyer-Picard MT; Kujas M
    Acta Neurochir (Wien); 1992; 115(1-2):20-30. PubMed ID: 1595392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of progestin and estrogen receptors in human meningiomas.
    Gabos S; Berkel J
    Neuroepidemiology; 1992; 11(4-6):255-60. PubMed ID: 1291889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas.
    Piantelli M; Rinelli A; Macrì E; Maggiano N; Larocca LM; Scerrati M; Roselli R; Iacoangeli M; Scambia G; Capelli A
    Cancer; 1993 Jan; 71(1):193-8. PubMed ID: 8416715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular biology of hormone and growth factor receptors in meningiomas.
    Black P; Carroll R; Zhang J
    Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of estradiol and progesterone receptors in meningioma].
    Lesch KP; Fahlbusch R
    Neurochirurgia (Stuttg); 1986 Jul; 29(4):99-104. PubMed ID: 3748266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of progesterone receptors in arachnoid granulations and in the lining of arachnoid cysts: its relevance to expression of progesterone receptors in meningiomas.
    Verhagen A; Go KG; Visser GM; Blankenstein MA; Vaalburg W
    Br J Neurosurg; 1995; 9(1):47-50. PubMed ID: 7786426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone receptors in initially excised versus recurrent intracranial meningiomas.
    Rubinstein AB; Loven D; Geier A; Reichenthal E; Gadoth N
    J Neurosurg; 1994 Aug; 81(2):184-7. PubMed ID: 8027799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex hormone receptors in intracranial tumours and normal brain.
    Whittle IR; Hawkins RA; Miller JD
    Eur J Surg Oncol; 1987 Aug; 13(4):303-7. PubMed ID: 3622783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features.
    Markwalder TM; Zava DT; Goldhirsch A; Markwalder RV
    Surg Neurol; 1983 Jul; 20(1):42-7. PubMed ID: 6867927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningiomas and hormonal receptors. Immunohistochemical study in typical and non-typical tumors.
    Hilbig A; Barbosa-Coutinho LM
    Arq Neuropsiquiatr; 1998 Jun; 56(2):193-9. PubMed ID: 9698727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.
    Kuratsu JI; Seto H; Kochi M; Ushio Y
    Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of meningioma hormone receptor status with hormone sensitivity in a tumor stem-cell assay.
    Grunberg SM; Daniels AM; Muensch H; Daniels JR; Bernstein L; Kortes V; Weiss MH
    J Neurosurg; 1987 Mar; 66(3):405-8. PubMed ID: 3819835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progestin receptors in meningiomas: clinicopathological correlations.
    Markwalder TM; Markwalder RV; Zava DT
    Clin Neuropharmacol; 1984; 7(4):368-74. PubMed ID: 6509449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations of female steroid hormone receptors with histologic features in meningiomas.
    Piquer J; Cerda M; Lluch A; Barcia Salorio JL; Garcia-Conde J
    Acta Neurochir (Wien); 1991; 110(1-2):38-43. PubMed ID: 1882717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
    Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
    Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
    Strojan P; Popović M; Jereb B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone and oestrogen receptors in meningiomas: biochemical and clinicopathological considerations.
    Whittle IR; Foo MS; Besser M; Vanderfield GK
    Aust N Z J Surg; 1984 Aug; 54(4):325-30. PubMed ID: 6593026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.